ANXA1 (Annexin A1) derived peptide. Blocks the competition of ANXA1 with the E3 ubiquitin ligase Cbl for EpHA2 binding, leading to downregulation of EphA2 expression and inhibition of nasopharyngeal carcinoma (NPC) growth and metastasis.
Y-27632 is a selective ROCK inhibitor. Frequently used 3D growth matrix component and for production of organoids. Also used when inducing neurons from fibroblasts. Manufactured to a high degree of optical purity.